BamSEC and AlphaSense Join Forces
Learn More

Optimer Pharmaceuticals Inc

Formerly NASDAQ: OPTR
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 425 90 pages Cubist Pharmaceuticals, Inc. 1.875% Convertible Senior Notes Due 2020 Indenture Dated as of September 10, 2013 the Bank of New York Mellon Trust Company, N.A., as Trustee
12/34/56
EX-4.1
from 425 90 pages Cubist Pharmaceuticals, Inc. 1.125% Convertible Senior Notes Due 2018 Indenture Dated as of September 10, 2013 the Bank of New York Mellon Trust Company, N.A., as Trustee
12/34/56
EX-4.1
from 8-K 69 pages Stockholder Protection Rights Agreement Dated as of February 26, 2013 Between Optimer Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC, as Rights Agent Stockholder Protection Rights Agreement
12/34/56
EX-4.12
from S-3 15 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.11
from S-3 16 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.10
from S-3 17 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.7
from S-3 36 pages Optimer Pharmaceuticals, Inc. and [Trustee], Trustee Indenture Dated as of [ ], 20 Subordinated Debt Securities
12/34/56
EX-4.6
from S-3 35 pages Optimer Pharmaceuticals, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ], 20 Senior Debt Securities
12/34/56
EX-4.13
from S-3 16 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.12
from S-3 17 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.11
from S-3 18 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.8
from S-3 39 pages Optimer Pharmaceuticals, Inc. and [Trustee], Trustee Indenture Dated as of [ ], 200 Subordinated Debt Securities
12/34/56
EX-4.7
from S-3 38 pages Optimer Pharmaceuticals, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ], 200 Senior Debt Securities
12/34/56
EX-4.1
from 8-K 9 pages Optimer Pharmaceuticals, Inc. Warrant to Purchase Common Stock to Purchase [ ] Shares of Common Stock
12/34/56
EX-4.13
from S-3 16 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.12
from S-3 17 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.11
from S-3 18 pages Optimer Pharmaceuticals, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Optimer Pharmaceuticals, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.8
from S-3 39 pages Optimer Pharmaceuticals, Inc. and [Trustee], Trustee Indenture Dated as of [ ], 200 Subordinated Debt Securities
12/34/56
EX-4.7
from S-3 38 pages Optimer Pharmaceuticals, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ], 200 Senior Debt Securities
12/34/56
EX-4.4
from 8-K 61 pages Registration Rights Agreement
12/34/56